GGrantIndex
Sort

30,917 grants matching tumor microenvironment

TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION

$613,059
Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance

$613,017
Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2021 · CA

Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.

$613,008
Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2023 · NS

Dissecting Phenotype Switching in Early Stage Melanomas

$612,946
Markus Schober · New York University School Of Medicine · R01 · FY2023 · CA

Project 1 - Evolutionary and ecological dynamics of tumor-host interactions

$612,755
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2015 · CA

Strategies for Cancer Vaccine Development: Preclinical Studies

$612,693
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Novel dietary interventions for reducing obesity-associated breast cancer

$612,513
Paul S Maclean · University Of Colorado Denver · R01 · FY2024 · CA

Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche

$612,460
Russell S Taichman · University Of Michigan At Ann Arbor · U54 · FY2012 · CA

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2023 · EB

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2022 · EB

The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking

$612,310
Kim Butts Pauly · Stanford University · R01 · FY2019 · CA

MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors

$612,302
Max Wintermark · Stanford University · R01 · FY2019 · CA

The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity

$612,272
David G Denardo · Washington University · U01 · FY2024 · CA

Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut

$612,247
Michael Lawrence Dougan · Massachusetts General Hospital · R01 · FY2022 · AI

Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics

$612,218
Joe Y Tien · Boston University (Charles River Campus) · U01 · FY2021 · CA

In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy

$612,076
Konstantin V Sokolov · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Mechanism of lysyl oxidase propeptide in oral squamous cell carcinoma microenvironments

$612,048
Philip C Trackman · Ada Forsyth Institute, Inc. · R56 · FY2024 · DE

A novel paradigm of sensitization of the tumor microenvironment with image-guided ultrasound cavitation and mechanotherapeutics for targeted HCC treatment

$612,024
Michalakis Averkiou · University Of Washington · R01 · FY2023 · EB

A “STICK” theranostic nanoplatform for image-guided drug delivery to brain malignancies

$611,998
Yuanpei Li · University Of California At Davis · R01 · FY2023 · EB

Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)

$611,983
Jenny C-N Chang · Methodist Hospital Research Institute · R01 · FY2024 · CA

Cell density effects on therapeutic sensitivity

$611,961
Jayne Stommel · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Training in Areas Fundamental to Cancer Research

$611,949
Ashani T Weeraratna · Johns Hopkins University · T32 · FY2024 · CA

Immune Impact on Cancer Chemoresistance

$611,871
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2018 · CA

Ovarian Cancer Chemoprevention

$611,847
Doris Mangiaracina Benbrook · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2015 · CA

Construction of A Lung Cancer Preclinical Model Cross-comparison Platform

$611,831
Ling Cai · Ut Southwestern Medical Center · R01 · FY2025 · CA